|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-4-9
|
|
pubmed:abstractText |
ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) showed in hypertensive patients that blood pressure-lowering treatment with an amlodipine-based regimen reduces events compared with an atenolol-based regimen and that atorvastatin was more effective than placebo.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
T
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1170-7690
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
221-30
|
|
pubmed:meshHeading |
pubmed-meshheading:19354342-Adrenergic beta-Antagonists,
pubmed-meshheading:19354342-Amlodipine,
pubmed-meshheading:19354342-Antihypertensive Agents,
pubmed-meshheading:19354342-Atenolol,
pubmed-meshheading:19354342-Calcium Channel Blockers,
pubmed-meshheading:19354342-Cardiovascular Diseases,
pubmed-meshheading:19354342-Cost-Benefit Analysis,
pubmed-meshheading:19354342-Drug Therapy, Combination,
pubmed-meshheading:19354342-Heptanoic Acids,
pubmed-meshheading:19354342-Humans,
pubmed-meshheading:19354342-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19354342-Hypertension,
pubmed-meshheading:19354342-Models, Economic,
pubmed-meshheading:19354342-Pyrroles,
pubmed-meshheading:19354342-Scandinavia,
pubmed-meshheading:19354342-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.
|
|
pubmed:affiliation |
i3 Innovus, Stockholm, Sweden. peter.lindgren@i3innovus.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
